Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on January 25, 2012, covering events occurring on January 19, 2012. The filing addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased the number of directors from seven to eight, effective January 19, 2012.
- New Director Election: Wade D. Miquelon was elected to fill the vacancy created by the board expansion.
- Term and Committee: Mr. Miquelon's initial term expires at the 2014 annual meeting of stockholders. He is expected to serve on the Audit Committee.
- Background: Mr. Miquelon is the Executive Vice President and Chief Financial Officer of Walgreen Co. (since July 2009) and previously served as CFO of Tyson Foods, Inc. (2006-2008).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the effective date of the Board expansion (January 19, 2012).
- Verify Wade D. Miquelon's appointment to the Audit Committee.
- Review the press release filed as Exhibit 99 for additional details on the new director's qualifications.